Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,337,000 | 9,888,000 | 6,526,000 | 4,111,000 | 8,085,000 |
| Depreciation Amortization | 5,293,000 | 4,026,000 | 2,694,000 | 1,351,000 | 5,576,000 |
| Income taxes - deferred | -1,945,000 | -1,266,000 | -393,000 | -314,000 | -1,457,000 |
| Accounts receivable | -172,000 | N/A | N/A | N/A | -803,000 |
| Other Working Capital | 3,016,000 | -491,000 | -633,000 | -1,458,000 | -797,000 |
| Other Operating Activity | -7,935,000 | 961,000 | 910,000 | 271,000 | 4,129,000 |
| Operating Cash Flow | $17,594,000 | $13,118,000 | $9,104,000 | $3,961,000 | $14,733,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,174,000 | 8,874,000 | 7,576,000 | 7,703,000 | -1,261,000 |
| PPE Investments | -2,050,000 | -1,438,000 | -887,000 | -418,000 | -2,106,000 |
| Net Acquisitions | -2,120,000 | -1,967,000 | -1,975,000 | -1,433,000 | -1,977,000 |
| Purchase Of Investment | -1,925,000 | -835,000 | -248,000 | -216,000 | -687,000 |
| Sale Of Investment | 233,000 | 229,000 | 47,000 | 4,000 | 1,309,000 |
| Other Investing Activity | -211,000 | -197,000 | -191,000 | -209,000 | -350,000 |
| Investing Cash Flow | $5,101,000 | $4,666,000 | $4,322,000 | $5,431,000 | $-5,072,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,040,000 | 993,000 | 938,000 | 826,000 | 1,124,000 |
| Debt Issued | 1,050,000 | 1,051,000 | 1,054,000 | 1,035,000 | 1,021,000 |
| Debt Repayment | -55,000 | -55,000 | -2,000 | -1,000 | -1,039,000 |
| Common Stock Issued | 732,000 | 593,000 | 318,000 | 173,000 | 451,000 |
| Common Stock Repurchased | -6,979,000 | -4,496,000 | -2,000,000 | -1,000,000 | -3,797,000 |
| Dividend Paid | -6,919,000 | -5,211,000 | -3,468,000 | -1,743,000 | -5,555,000 |
| Other Financing Activity | -11,969,000 | -11,721,000 | -10,583,000 | -8,056,000 | -1,427,000 |
| Financing Cash Flow | $-23,100,000 | $-18,846,000 | $-13,743,000 | $-8,766,000 | $-9,222,000 |
| Exchange Rate Effect | -15,000 | -8,000 | -9,000 | -4,000 | N/A |
| Beginning Cash Position | 2,247,000 | 2,247,000 | 2,247,000 | 2,247,000 | 1,808,000 |
| End Cash Position | 1,827,000 | 1,177,000 | 1,921,000 | 2,869,000 | 2,247,000 |
| Net Cash Flow | $-420,000 | $-1,070,000 | $-326,000 | $622,000 | $439,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,594,000 | 13,118,000 | 9,104,000 | 3,961,000 | 14,733,000 |
| Capital Expenditure | -2,050,000 | -1,438,000 | -887,000 | -418,000 | -2,106,000 |
| Free Cash Flow | 15,544,000 | 11,680,000 | 8,217,000 | 3,543,000 | 12,627,000 |